Analysis SHL Telemedicine Ltd. (0QMX)
5/31/2024
Analysis of SHL Telemedicine Ltd. (0QMX)
SHL Telemedicine Ltd. is showing a stable trend in its stock price, with the price closing around 5.25 on the most recent trading day. The Relative Strength Index (RSI) is indicating a value of 56.13, which suggests the stock is neither overbought nor oversold.Looking at the Moving Average Convergence Divergence (MACD) indicator, it seems to be not available for the recent data points, indicating a lack of clear trend direction based on this indicator.
The Moving Average (MA) indicator is showing a value of 7.14, which is higher than the current closing price, indicating a potential bullish signal. However, the Simple Moving Average (SMA) and Exponential Moving Average (EMA) are not available for the recent data points.
Overall, based on the available data, SHL Telemedicine Ltd. seems to be in a stable position with a neutral RSI and a potential bullish signal from the MA indicator. It would be important to monitor the MACD indicator and other moving averages for further insights into the stock's trend.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods, with the highest growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
It can be observed that the company is expected to experience a significant increase in growth rate compared to the past 5 years, with a particularly high growth rate projected for the next 5 years. This indicates positive expectations and potential for expansion and development in the near future.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price of the security is $191.57, which is below the median and average forecasted prices. This suggests that there is some uncertainty among analysts about the future direction of the security's price.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 31, 2024. The company shows good returns on assets and equity.
Moving on to stock statistics, the short ratio is low, indicating low investor sentiment for shorting the stock. The company has a significant percentage of shares held by institutions. The stock price has a beta of 1.264, and the fifty-two-week range shows a moderate change.
Valuation metrics reveal a high PEG ratio and forward PE ratio, with the stock being relatively expensive based on price to book and price to sales ratios. The company's market capitalization and enterprise value are substantial.
The stock price summary shows moving averages and the range of prices over the past year.
Lastly, dividends and splits information includes details about dividend rates, yields, and important dates related to dividends and stock splits.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential challenge in managing production or procurement costs.
3. The gross profit margin has remained relatively stable over the years, indicating that the company has been able to maintain profitability despite the increase in sales and cost of goods sold.
4. Operating income has also shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020, indicating efficient management of operating expenses.
5. Net income has been increasing over the years, reaching $97 billion in 2023 from $57.4 billion in 2020, showing that the company has been able to translate its revenue growth into bottom-line profitability.
6. Earnings per share (EPS) have also been on the rise, indicating that the company's profitability growth is being distributed among shareholders.
7. The company has been able to generate consistent EBITDA figures, showing its ability to generate cash flow from its core operations.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a healthy growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There has been a consistent increase in shareholders' equity, indicating a positive trend in the company's financial health.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show significant fluctuations, with large amounts being spent on common stock repurchase and debt issuance/payment.
4. Investing activities also vary, with notable amounts being spent on the sale and purchase of investments.
5. The end cash position has been fluctuating, but overall, the company has maintained a healthy cash reserve.
6. Interest paid and income tax paid have also varied over the years, impacting the company's cash flow position.
7. Stock-based compensation is a significant factor in the company's cash flow statement, indicating the use of equity as a form of compensation.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates show an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
